
Michael S. Brooke
Examiner (ID: 8555)
| Most Active Art Unit | 2853 |
| Art Unit(s) | 2853 |
| Total Applications | 507 |
| Issued Applications | 449 |
| Pending Applications | 14 |
| Abandoned Applications | 44 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16876837
[patent_doc_number] => 11026957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands
[patent_app_type] => utility
[patent_app_number] => 16/863530
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16603
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863530
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863530 | Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands | Apr 29, 2020 | Issued |
Array
(
[id] => 16312255
[patent_doc_number] => 20200290993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => TLR INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/861142
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 486
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16861142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/861142 | TLR inhibitors | Apr 27, 2020 | Issued |
Array
(
[id] => 16444836
[patent_doc_number] => 10836748
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Bradykinin B2 receptor antagonists
[patent_app_type] => utility
[patent_app_number] => 16/861131
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19287
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 490
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16861131
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/861131 | Bradykinin B2 receptor antagonists | Apr 27, 2020 | Issued |
Array
(
[id] => 20172926
[patent_doc_number] => 12391657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Small molecules that bind and/or modulate differentforms of tau oligomers
[patent_app_type] => utility
[patent_app_number] => 17/606004
[patent_app_country] => US
[patent_app_date] => 2020-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 10761
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606004
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606004 | Small molecules that bind and/or modulate differentforms of tau oligomers | Apr 22, 2020 | Issued |
Array
(
[id] => 17687615
[patent_doc_number] => 20220194907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => PROCESS FOR THE PREPARATION OF MICROBIOCIDAL OXADIAZOLE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/594469
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 709
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594469 | Process for the preparation of microbiocidal oxadiazole derivatives | Apr 15, 2020 | Issued |
Array
(
[id] => 16476123
[patent_doc_number] => 10851050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Biaryl urea derivative or salt thereof and preparation process and use for the same
[patent_app_type] => utility
[patent_app_number] => 16/850882
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24981
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 258
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16850882
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/850882 | Biaryl urea derivative or salt thereof and preparation process and use for the same | Apr 15, 2020 | Issued |
Array
(
[id] => 16204718
[patent_doc_number] => 20200237708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => 9,10-Alpha,Alpha-OH-Taxane Analogs and Methods for Production Thereof
[patent_app_type] => utility
[patent_app_number] => 16/849879
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16849879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/849879 | 9,10-Alpha,Alpha-OH-Taxane Analogs and Methods for Production Thereof | Apr 14, 2020 | Abandoned |
Array
(
[id] => 17755536
[patent_doc_number] => 11395814
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-26
[patent_title] => Compounds and forms of treatment for female sexual disorders
[patent_app_type] => utility
[patent_app_number] => 16/848824
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 26132
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/848824 | Compounds and forms of treatment for female sexual disorders | Apr 13, 2020 | Issued |
Array
(
[id] => 17742560
[patent_doc_number] => 11390617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Methods of treating non-Hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
[patent_app_type] => utility
[patent_app_number] => 16/844407
[patent_app_country] => US
[patent_app_date] => 2020-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 27025
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16844407
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/844407 | Methods of treating non-Hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione | Apr 8, 2020 | Issued |
Array
(
[id] => 17595201
[patent_doc_number] => 20220144774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => PROCESSES FOR PREPARING (3R,4R)-1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE OR A SALT THEREOF AND PROCESSES FOR PREPARING TOFACITINIB USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/594062
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594062
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594062 | Processes for preparing (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine or a salt thereof and processes for preparing tofacitinib using the same | Apr 2, 2020 | Issued |
Array
(
[id] => 17704464
[patent_doc_number] => 20220204470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => APPARATUS FOR AND METHOD OF CONVERTING CBD AND/OR CBD DERIVATIVES TO AT LEAST ONE OTHER TYPE OF CANNABINOID AND/OR CANNABINOID DERIVATIVE SUCH AS THC
[patent_app_type] => utility
[patent_app_number] => 17/601636
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601636
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601636 | APPARATUS FOR AND METHOD OF CONVERTING CBD AND/OR CBD DERIVATIVES TO AT LEAST ONE OTHER TYPE OF CANNABINOID AND/OR CANNABINOID DERIVATIVE SUCH AS THC | Apr 2, 2020 | Abandoned |
Array
(
[id] => 17734641
[patent_doc_number] => 20220220100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => PHOTOCHROMIC AND ELECTROCHROMIC DIARYLETHENE COMPOUNDS WITH IMPROVED PHOTOSTABILITY AND SOLUBILITY
[patent_app_type] => utility
[patent_app_number] => 17/601096
[patent_app_country] => US
[patent_app_date] => 2020-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601096
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601096 | PHOTOCHROMIC AND ELECTROCHROMIC DIARYLETHENE COMPOUNDS WITH IMPROVED PHOTOSTABILITY AND SOLUBILITY | Apr 1, 2020 | Abandoned |
Array
(
[id] => 17595215
[patent_doc_number] => 20220144788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/599993
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599993
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599993 | SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS | Mar 26, 2020 | Abandoned |
Array
(
[id] => 17721633
[patent_doc_number] => 20220214355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => SULFUR-HETEROCYCLE EXCHANGE CHEMISTRY AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/441544
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441544
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/441544 | Sulfur-heterocycle exchange chemistry and uses thereof | Mar 22, 2020 | Issued |
Array
(
[id] => 17769332
[patent_doc_number] => 11401257
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
[patent_app_type] => utility
[patent_app_number] => 16/823120
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 34657
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823120
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823120 | Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses | Mar 17, 2020 | Issued |
Array
(
[id] => 20701618
[patent_doc_number] => 12624318
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-12
[patent_title] => Cleaning agent composition and cleaning method
[patent_app_type] => utility
[patent_app_number] => 17/438606
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5898
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438606
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/438606 | Cleaning agent composition and cleaning method | Mar 10, 2020 | Issued |
Array
(
[id] => 19550904
[patent_doc_number] => 12134600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-05
[patent_title] => Method for producing a vadadustat intermediate
[patent_app_type] => utility
[patent_app_number] => 17/605408
[patent_app_country] => US
[patent_app_date] => 2020-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9995
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605408
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605408 | Method for producing a vadadustat intermediate | Mar 4, 2020 | Issued |
Array
(
[id] => 16341587
[patent_doc_number] => 20200306237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME
[patent_app_type] => utility
[patent_app_number] => 16/809045
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16809045
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/809045 | Methods of diagnosing and treating Tourette syndrome | Mar 3, 2020 | Issued |
Array
(
[id] => 17134760
[patent_doc_number] => 11136306
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-peridine-2,6-dione
[patent_app_type] => utility
[patent_app_number] => 16/807020
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 54
[patent_no_of_words] => 10485
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807020
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/807020 | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-peridine-2,6-dione | Mar 1, 2020 | Issued |
Array
(
[id] => 19701462
[patent_doc_number] => 12195471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Salt of aldose reductase inhibitor, and preparation method and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/434591
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3415
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/434591 | Salt of aldose reductase inhibitor, and preparation method and application thereof | Feb 27, 2020 | Issued |